FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.04.2019
End date : 31.03.2020
Previous studies demonstrated a prognostic relevance of several molecular markers in stage T1 bladder cancer. These might optimize risk stratification and decision making with regard to immediate cystectomy or bladder sparing approach. However, these findings have not been validated yet. The goal of the current study is to validate the association of the mRNA expression of these molecular markers with clinical and survival data in a new cohort consisting of stage T1 bladder cancer.